8-K - aTYR PHARMA INC (0001339970) (Filer)
Published . Updated .
Key takeaways
- 8-K - aTYR PHARMA filed an 8-K with the SEC on Nov 13 (a notice of a material company event).
- Exposed: ATYR
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - aTYR PHARMA filed an 8-K with the SEC on Nov 13 (a notice of a material company event).
Directly affected
- ATYR aTYR PHARMA
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- LLY Eli Lilly and
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- JNJ Johnson & Johnson
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- PFE Pfizer
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- MRK Merck
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ATYR | +24.39% | +13.50% | base | after close | after close | after close | after close |
| XLV | -0.28% | +0.04% | base | after close | after close | after close | after close |
| XBI | +4.20% | +3.78% | base | after close | after close | after close | after close |
| LLY | -2.25% | -0.49% | base | after close | after close | after close | after close |
| JNJ | -1.35% | -1.97% | base | after close | after close | after close | after close |
| PFE | +1.19% | +1.90% | base | after close | after close | after close | after close |
| MRK | +0.65% | -0.38% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-13 AccNo: 0001339970-26-000088 Size: 165 KB Item 8.01: Other Events
Source: sec-edgar
The price since 13 Nov 2026: aTYR PHARMA (ATYR) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| aTYR PHARMA (ATYR) | three days earlier | +13.50% | final price |
| aTYR PHARMA (ATYR) | five days earlier | +24.39% | final price |
| JNJ | three days earlier | -1.97% | final price |
| JNJ | five days earlier | -1.35% | final price |
| LLY | three days earlier | -0.49% | final price |
| LLY | five days earlier | -2.25% | final price |
| MRK | three days earlier | -0.38% | final price |
| MRK | five days earlier | +0.65% | final price |
| PFE | three days earlier | +1.90% | final price |
| PFE | five days earlier | +1.19% | final price |
| XBI | three days earlier | +3.78% | final price |
| XBI | five days earlier | +4.20% | final price |
| XLV | three days earlier | +0.04% | final price |
| XLV | five days earlier | -0.28% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 24 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 70 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 37 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 44 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 70 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 84 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 86 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around aTYR PHARMA (ATYR)
Companies carried with this story
- ATYR aTYR PHARMA
For “8-K - aTYR PHARMA INC (0001339970) (Filer),” aTYR PHARMA (ATYR) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ATYR
How “8-K - aTYR PHARMA INC (0001339970) (Filer)” reaches aTYR PHARMA (ATYR)
“8-K - aTYR PHARMA INC (0001339970) (Filer)” (13 Nov 2026) reaches aTYR PHARMA (ATYR) through this story.
What ties aTYR PHARMA (ATYR) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> ATYR
Price levels for aTYR PHARMA (ATYR)
ATYR traded between 0.10 and 7.91 across 20 sessions. The latest close on file is 6.39.
How solid “8-K - aTYR PHARMA INC (0001339970) (Filer)” looks
14 out of 100
“8-K - aTYR PHARMA INC (0001339970) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.